Legal Representation
Attorney
William C. Schrot
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 17, 2016 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 17, 2016 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 15, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 19, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 19, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 30, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 14, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 14, 2015 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 14, 2015 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 14, 2015 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 14, 2015 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 11, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 10, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 10, 2015 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 10, 2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 10, 2015 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 10, 2015 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 4, 2015 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 5, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 28, 2015 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Business development services, namely, assistance in product commercialization for third parties of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Production, namely, pharmaceutical product and drug development; Drug discovery and research, and development of pharmaceuticals and substances in the nature of polypeptides, particularly antibodies and antibody derivatives, for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Drug discovery and research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of pharmaceutical and biotechnology products; Providing medical and scientific research information in the field of pharmaceuticals and biotechnology
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
035
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"MEDICINES"